Loading...

Home
ETF
ASMB

ASMB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ASMB News

Gilead Licenses Assembly Bio's HSV Programs, Secures $35 Million Investment

Dec 22 2025Benzinga

Gilead Secures Exclusive License for Assembly Bio's HSV Programs, Receives $35M Payment

Dec 22 2025NASDAQ.COM

Gilead Activates License for Assembly Biosciences' Herpes Initiatives

Dec 22 2025SeekingAlpha

Assembly Software Reports 350% Year-over-Year Growth in NeosAI Adoption for 2025

Dec 17 2025Globenewswire

Assembly Unveils Encouraging Initial Trial Findings for ABI-1179 and ABI-5366 in Recurrent Genital Herpes

Dec 09 2025NASDAQ.COM

After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences

Dec 09 2025NASDAQ.COM

Assembly Bio Reports Significant Interim Results for Two HSV-2 Therapeutics

Dec 08 2025Globenewswire

Assembly Bio Reports Significant Phase 1b Results for ABI-1179 and ABI-5366 Antiviral Candidates

Dec 08 2025Newsfilter

Mizuho Keeps Outperform Rating for Assembly Biosciences and Increases Price Target to $40

Nov 20 2025Benzinga

IRON Strengthens, MNMD Offers Reassurance to Investors, Could NKTR Experience an Early Christmas?

Oct 19 2025NASDAQ.COM

Assembly Biosciences Unveils Interim Phase 1b Results for HSV Helicase-Primase Inhibitor ABI-5366 at the 38th IUSTI Europe Congress on Sexually Transmitted Infections

Oct 10 2025Newsfilter

4 Biotechnology Stocks Leading the Way with Strong Momentum and Technical Performance

Sep 29 2025Benzinga

JMP Securities Begins Coverage of Assembly Biosciences (ASMB) with a Positive Market Outlook

Sep 25 2025NASDAQ.COM

JMP Securities Begins Coverage of Assembly Biosciences, Assigns Market Outperform Rating and Sets Price Target at $38

Sep 24 2025Benzinga

Guggenheim Reaffirms Buy Rating on Assembly Biosciences, Increases Price Target to $39

Sep 08 2025Benzinga

HC Wainwright & Co. Initiates Coverage on Assembly Biosciences with a Buy Rating and Sets Price Target at $50

Aug 18 2025Benzinga